Lewis Asset Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-4,942
Closed -$425K 135
2024
Q4
$425K Sell
4,942
-530
-10% -$57.3K 0.32% 78
2024
Q3
$652K Buy
5,472
+182
+3% +$24.3K 0.48% 55
2024
Q2
$755K Sell
5,290
-200
-4% -$26.5K 0.58% 39
2024
Q1
$705K Hold
5,490
0.58% 38
2023
Q4
$568K Buy
+5,490
New +$543K 0.52% 49

Other funds holding NVO

Lewis Asset Management's NVO Position: Q1 2025 in Review

Lewis Asset Management sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 4,942 shares — an estimated $425K sold.

Lewis Asset Management first reported a position in NVO in Q4 2023 and held it in 5 quarters. The position peaked at $755K in Q2 2024. 1,528 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • Lewis Asset Management reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
  • Lewis Asset Management sold 4,942 Novo Nordisk shares in Q1 2025, an estimated $425K.
  • Lewis Asset Management first reported a position in Novo Nordisk in Q4 2023 and held it in 5 quarters.
  • Lewis Asset Management's Novo Nordisk position peaked at $755K in Q2 2024.
  • 1,528 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on Lewis Asset Management's 13F filing for Q1 2025, filed 5 May 2025.